<unk>  is a Thiazolidinedione that is FDA approved for the treatment of glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulfonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulfonylurea alone. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include edema, edema of lower extremity, hypoglycemia, weight increased, diarrhea, nausea, backache, myalgia, pain in limb, headache, urinary tract infectious disease, pharyngitis, sinusitis, upper respiratory infection, accidental injury, influenza.
Pioglitazone/Glimepiride
Pioglitazone And Metformin hydrochloride
Sitagliptin And Metformin Hydrochloride
Rosiglitazone
Dapagliflozin / saxagliptin
Insulin glulisine
Liraglutide
Repaglinide and Metformin hydrochloride